JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skoczynska, A.
Right arrow Articles by Hryniewicz, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skoczynska, A.
Right arrow Articles by Hryniewicz, W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2005, p. 938-941, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.938-941.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Prevalence and Serotype Distribution of Encapsulated Haemophilus influenzae Isolates from Patients with Lower Respiratory Tract Infections in Poland

Anna Skoczynska,1* Magdalena Lewandowska,2,{dagger} Anna Klarowicz,1 and Waleria Hryniewicz1

Department of Epidemiology and Clinical Microbiology, National Institute of Public Health,1 Department of Microbial Biochemistry, Institute of Biochemistry and Biophysics of the Polish Academy of Sciences, Warsaw, Poland2

Received 13 July 2004/ Returned for modification 30 August 2004/ Accepted 8 October 2004

Among 1,272 H. influenzae isolates obtained from patients with lower respiratory tract infections, 5.6% were found to be encapsulated. The most common were serotypes b (40.3%) and e (38.9%) followed by serotypes f (16.7%) and d (4.1%). All encapsulated isolates within a particular serotype showed high genetic homogeneity and did not produce ß-lactamases.


* Corresponding author. Mailing address: Department of Epidemiology and Clinical Microbiology, National Institute of Public Health, Chelmska 30/34, 00-725 Warsaw, Poland. Phone: 48 22 8514670. Fax: 48 22 8412949. E-mail: skoczek{at}cls.edu.pl.

{dagger} Present address: Department of Microbial Biochemistry, Institute of Biochemistry and Biophysics of the Polish Academy of Sciences, Warsaw, Poland.


Journal of Clinical Microbiology, February 2005, p. 938-941, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.938-941.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.